GlassScriptPhysician profile
Alyssa Althoff
NPI 1255891107
$35,122.75
in general payments reported to CMS, 2019-2025
8 companies · $11K in 2025
The $11K reported for 2025 was more than what 88% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $24.14 · 2023: $17K · 2024: $6,455 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $29K · Travel and Lodging: $3,740 · Food and Beverage: $2,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $29,285.76 |
| Travel and Lodging | $3,739.64 |
| Food and Beverage | $2,073.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $18,639.33 | 2023-2025 | |
| Smith+Nephew, INC. | $12,281.67 | 2024-2025 | Bone Anchors With Arthroscopic Delivery System, Q-Fix |
| Stryker Corporation | $2,717.49 | 2023-2025 | Blueprint Patient Specific Instrumentation, Inspace, Aequalis Perform |
| Peerless Surgical INC. | $933.83 | 2025 | |
| Suvon Surgical LLC | $325.44 | 2025 | |
| Miach Orthopaedics, INC. | $184.01 | 2025 | |
| Fortis Surgical, LLC | $24.14 | 2022 | |
| Ferring Pharmaceuticals INC. | $16.84 | 2025 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Althoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.